skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Cancers remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away
The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away

Nagai, Yuya ; Ambinder, Alexander J

Cancers, 2023-07, Vol.15 (14), p.3535 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
2
Evolving Treatment Strategies for Elderly Leukemia Patients with IDH Mutations
Evolving Treatment Strategies for Elderly Leukemia Patients with IDH Mutations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evolving Treatment Strategies for Elderly Leukemia Patients with IDH Mutations

Buege, Michael J ; DiPippo, Adam J ; DiNardo, Courtney D

Cancers, 2018-06, Vol.10 (6), p.187 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
3
Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism
Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism

Tsesmetzis, Nikolaos ; Paulin, Cynthia B J ; Rudd, Sean G ; Herold, Nikolas

Cancers, 2018-07, Vol.10 (7), p.240 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
4
Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436
Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436
Material Type:
Artigo 		Adicionar ao Meu Espaço

Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436

Uckun, Fatih M. ; Watts, Justin ; Mims, Alice S. ; Patel, Prapti ; Wang, Eunice ; Shami, Paul J. ; Cull, Elizabeth ; Lee, Cynthia ; Cogle, Christopher R. ; Lin, Tara L.

Cancers, 2021-10, Vol.13 (21), p.5287 [Periódico revisado por pares]

Basel: MDPI AG

Texto completo disponível

Citações Citado por
5
Pitavastatin Is Anti-Leukemic in a Bone Marrow Microenvironment Model of B-Lineage Acute Lymphoblastic Leukemia
Pitavastatin Is Anti-Leukemic in a Bone Marrow Microenvironment Model of B-Lineage Acute Lymphoblastic Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pitavastatin Is Anti-Leukemic in a Bone Marrow Microenvironment Model of B-Lineage Acute Lymphoblastic Leukemia

Piktel, Debbie ; Nair, Rajesh R ; Rellick, Stephanie L ; Geldenhuys, Werner J ; Martin, Karen H ; Craig, Michael D ; Gibson, Laura F

Cancers, 2022-05, Vol.14 (11), p.2681 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
6
The role of nrf2 and cytoprotection in regulating chemotherapy resistance of human leukemia cells
The role of nrf2 and cytoprotection in regulating chemotherapy resistance of human leukemia cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

The role of nrf2 and cytoprotection in regulating chemotherapy resistance of human leukemia cells

Rushworth, Stuart A ; Macewan, David J

Cancers, 2011-03, Vol.3 (2), p.1605-1621 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
7
An RNA Aptamer Targets the PDZ-Binding Motif of the HPV16 E6 Oncoprotein
An RNA Aptamer Targets the PDZ-Binding Motif of the HPV16 E6 Oncoprotein
Material Type:
Artigo 		Adicionar ao Meu Espaço

An RNA Aptamer Targets the PDZ-Binding Motif of the HPV16 E6 Oncoprotein

Belyaeva, Tamara A ; Nicol, Clare ; Cesur, Ozlem ; Travé, Gilles ; Blair, George Eric ; Stonehouse, Nicola J

Cancers, 2014-07, Vol.6 (3), p.1553-1569 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
8
The Burden of Survivorship on Hematological Patients-Long-Term Analysis of Toxicities after Total Body Irradiation and Allogeneic Stem Cell Transplantation
The Burden of Survivorship on Hematological Patients-Long-Term Analysis of Toxicities after Total Body Irradiation and Allogeneic Stem Cell Transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Burden of Survivorship on Hematological Patients-Long-Term Analysis of Toxicities after Total Body Irradiation and Allogeneic Stem Cell Transplantation

Oertel, Michael ; Martel, Jonas ; Mikesch, Jan-Henrik ; Scobioala, Sergiu ; Reicherts, Christian ; Kröger, Kai ; Lenz, Georg ; Stelljes, Matthias ; Eich, Hans Theodor

Cancers, 2021-11, Vol.13 (22), p.5640 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
9
Pulmonary Toxicity after Total Body Irradiation-An Underrated Complication? Estimation of Risk via Normal Tissue Complication Probability Calculations and Correlation with Clinical Data
Pulmonary Toxicity after Total Body Irradiation-An Underrated Complication? Estimation of Risk via Normal Tissue Complication Probability Calculations and Correlation with Clinical Data
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pulmonary Toxicity after Total Body Irradiation-An Underrated Complication? Estimation of Risk via Normal Tissue Complication Probability Calculations and Correlation with Clinical Data

Oertel, Michael ; Kittel, Christopher ; Martel, Jonas ; Mikesch, Jan-Henrik ; Glashoerster, Marco ; Stelljes, Matthias ; Eich, Hans Theodor

Cancers, 2021-06, Vol.13 (12), p.2946 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
10
Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001)
Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001)

Park, Sung-Soo ; Shin, Seung-Hwan ; Lee, Jung-Yeon ; Jeon, Young-Woo ; Yhang, Seung-Ah ; Min, Chang-Ki

Cancers, 2023-09, Vol.15 (19), p.4783 [Periódico revisado por pares]

Basel: MDPI AG

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2014  (5)
  2. 2014Até2017  (2)
  3. 2018Até2020  (11)
  4. 2021Até2023  (49)
  5. Após 2023  (6)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.